James Stover, PhD, joined Natera in 2025 as general manager of health systems, where he leads the integration of genomic testing, population health, and AI-powered clinical decision support into large U.S. health systems. In this role, he oversees product strategy, commercialization, health system partnerships, and the development of new precision medicine platforms that support risk stratification, early disease detection, and improved clinical outcomes at scale.

Previously, Stover served as chief business development officer at Nashville Biosciences, where he played a central role in launching the company from Vanderbilt University Medical Center. He led the development of the company’s product and commercial strategy, and was instrumental in establishing the Alliance for Genomic Discovery, a nine-figure strategic partnership with leading pharmaceutical companies, supporting one of the fastest and most diverse whole-genome sequencing programs globally.

Stover also led corporate and business development at Aegis Sciences Corporation following the acquisition of Diagnovus, a venture-backed molecular diagnostics company he co-founded. Under his leadership, Diagnovus launched five novel clinical laboratory tests and secured multiple biopharma partnerships. He has also held positions at The Scripps Research Institute, Square 1 Bank, and Warburg Pincus.

Stover earned a bachelor’s degree in biochemistry from the University of Virginia (cum laude) and a PhD in chemistry from Vanderbilt University (summa cum laude), where he was a National Institutes of Health Fellow. He received the Tibbetts Award from the U.S. Small Business Administration for impact on the SBIR/STTR programs and is currently a member of the U.S. Men’s Senior National Soccer Team.